Once again, Brent Saunders is standing out from the pharma c-suite crowd.
Over the weekend, the Allergan chief executive was the only head of a major drug maker to publicly say anything about the highly controversial Trump immigration ban. And what Saunders had to say was not supportive, at all, of the move: Allergan, he tweeted, “is strong & bold b/c of diversity. Oppose any policy that puts limitations on our ability to attract the best & diverse talent.”
In a follow-up note to us, Saunders explained that he had not spoken with other pharma chief executives about the policy, but “for me, it was simple. [It’s] right versus wrong. We always need to speak up in these types of situations. Sad others don’t feel the same way.” And, he added, it “doesn’t mean I can’t work constructively with [the] Trump administration” on health care.
About the Author Reprints
